Discover
RKDA
Arcadia Biosciences, Inc.
0.16
1 x 0.14
2 x 0.36
bid
ask
-
0.01
7.39%
2 @ 06:01 PM
0.15 -0.01 (5.64%)
| Ytd | -92.03% | |
| 1y | -95.74% |
0.14
day range
0.17
0.11
52 week range
4.18
| Open | 0.15 | Prev Close | 0.17 | Low | 0.14 | High | 0.17 | Mkt Cap | 380.41K |
| Vol | 847.42K | Avg Vol | 1.91M | EPS | -4.55 | P/E | N/A | Forward P/E | -4.76 |
| Beta | N/A | Short Ratio | 0.73 | Inst. Own | 4.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-19 | 50-d Avg | 0.34 | 200-d Avg | 1.02 | 1yr Est | 9.00 |
| Income Statement | |||
| Total Revenue | 1.44M | ||
| Revenues (USD) | 1.44M | ||
| Cost of Revenue | 812.00K | ||
| Gross Profit | 631.00K | ||
| Operating Expenses | 1.13M | ||
| Selling, General and Administrative Expense | 1.13M | ||
| Operating Income | -496.00K | ||
| Net Income | -6.27M | ||
| Net Income Common Stock | -6.27M | ||
| Net Income Common Stock (USD) | -6.27M | ||
| Consolidated Income | -6.27M | ||
| Earnings per Basic Share | -2.09 | ||
| Earnings per Basic Share (USD) | -2.09 | ||
| Earnings per Diluted Share | -2.09 | ||
| Earning Before Interest & Taxes (EBIT) | -6.27M | ||
| Earning Before Interest & Taxes (USD) | -6.27M | ||
| Weighted Average Shares | 2.99M | ||
| Weighted Average Shares Diluted | 2.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.18M | ||
| Cash and Equivalents (USD) | 4.18M | ||
| Trade and Non-Trade Receivables | 559.00K | ||
| Current Assets | 5.74M | ||
| Total Assets | 5.89M | ||
| Current Liabilities | 1.65M | ||
| Total Liabilities | 5.26M | ||
| Accumulated Retained Earnings (Deficit) | -291.87M | ||
| Shareholders Equity | 633.00K | ||
| Shareholders Equity (USD) | 633.00K | ||
| Assets Non-Current | 154.00K | ||
| Goodwill and Intangible Assets | 39.00K | ||
| Inventory | 930.00K | ||
| Liabilities Non-Current | 3.61M | ||
| Trade and Non-Trade Payables | 1.38M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 3.54M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.22M | ||
| Issuance (Purchase) of Equity Shares | 3.94M | ||
| Net Cash Flow from Operations | -319.00K | ||
| Share Based Compensation | 14.00K | ||